{"id":951809,"date":"2026-04-15T16:31:17","date_gmt":"2026-04-15T20:31:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/"},"modified":"2026-04-15T16:31:17","modified_gmt":"2026-04-15T20:31:17","slug":"adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/","title":{"rendered":"Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SEATTLE, April  15, 2026  (GLOBE NEWSWIRE) &#8212; Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the first quarter 2026 after market close on Tuesday, May 5, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time.<\/p>\n<p align=\"left\">Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zrpK_qnFIWqznkRncpfVdYewH6jjCdZiKG5WbfsB1IU_DtiDX-ruFYyeFPhWAnS2pW-GUUx8MvGWbERNGqZuxefhvuwD2W2m_48ch0JJqqQ=\" rel=\"nofollow\" target=\"_blank\">www.adaptivebiotech.com<\/a>. The webcast will be archived and available for replay within 24 hours after the event.<\/p>\n<p align=\"left\">\n        <strong>About Adaptive Biotechnologies<\/strong>\n      <\/p>\n<p align=\"left\">Adaptive Biotechnologies (\u201cwe\u201d or \u201cour\u201d) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature\u2019s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. We apply our platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across our two business segments: Minimal Residual Disease (MRD) and Immune Medicine. Our commercial products and clinical pipeline enable the diagnosis, monitoring, and treatment of diseases such as cancer and autoimmune disorders. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.<\/p>\n<p align=\"left\">\n        <strong>ADAPTIVE INVESTORS<\/strong><br \/>\n        <br \/>Karina Calzadilla, Vice President, Investor Relations and FP&amp;A<br \/>201-396-1687<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yagBvQo25MO3SO__mAaxN_aDMWXobuG4wQWgaPiBfJOX_l6Xzd_gklW6Ra9hwxbvKjV-I_WTFXmzs6uoWhHhDl_IsVimZKwFvGyAlcwc0_NoCILGdgdG0DSiQKEwk6nQ\" rel=\"nofollow\" target=\"_blank\">investors@adaptivebiotech.com<\/a><\/p>\n<p align=\"left\">\n        <strong>ADAPTIVE MEDIA<\/strong><br \/>\n        <br \/>Erica Jones, Associate Corporate Communications Director<br \/>206-279-2423<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xiZJLDH5lR6jy7hvBcVWQznUMaomeGXVWZ3UkfXBHxQ5YZB9DHJtzR4vi5O6Izp6ULxCUVPi8FChyqmdYou4lm7yzIdjBT1uZFE7PBcNTmPrEO-wWj1X8YrtAsb0r1aavSCO5cx_pZGFR7pPJL3oJdFgdc_Zpri39L9FOutlzY1SBcIn6BnSK4v1vQsC3dvYX6dkgLRmfUueblBEuXcbDlj2LcwHbh5yQ4e1xzBPzyI0z_VLZIpAcQkUSJY5re1TS2gd1u_d4P9B0HziDXXOOQ==\" rel=\"nofollow\" target=\"_blank\">media@adaptivebiotech.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MDc0NiM3NTM4MTEwIzIxNzcxODI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MjRmNWU0OTUtNDMxOS00M2E3LWI3N2EtMjU1Zjg0NWIyMDMxLTExODg3NTItMjAyNi0wNC0xNS1lbg==\/tiny\/Adaptive-Biotechnologies.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SEATTLE, April 15, 2026 (GLOBE NEWSWIRE) &#8212; Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the first quarter 2026 after market close on Tuesday, May 5, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for replay within 24 hours after the event. About Adaptive Biotechnologies Adaptive Biotechnologies (\u201cwe\u201d or \u201cour\u201d) is a commercial-stage biotechnology &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-951809","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SEATTLE, April 15, 2026 (GLOBE NEWSWIRE) &#8212; Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the first quarter 2026 after market close on Tuesday, May 5, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for replay within 24 hours after the event. About Adaptive Biotechnologies Adaptive Biotechnologies (\u201cwe\u201d or \u201cour\u201d) is a commercial-stage biotechnology &hellip; Continue reading &quot;Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-15T20:31:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MDc0NiM3NTM4MTEwIzIxNzcxODI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026\",\"datePublished\":\"2026-04-15T20:31:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\\\/\"},\"wordCount\":293,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MDc0NiM3NTM4MTEwIzIxNzcxODI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\\\/\",\"name\":\"Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MDc0NiM3NTM4MTEwIzIxNzcxODI=\",\"datePublished\":\"2026-04-15T20:31:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MDc0NiM3NTM4MTEwIzIxNzcxODI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MDc0NiM3NTM4MTEwIzIxNzcxODI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/","og_locale":"en_US","og_type":"article","og_title":"Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026 - Market Newsdesk","og_description":"SEATTLE, April 15, 2026 (GLOBE NEWSWIRE) &#8212; Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the first quarter 2026 after market close on Tuesday, May 5, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for replay within 24 hours after the event. About Adaptive Biotechnologies Adaptive Biotechnologies (\u201cwe\u201d or \u201cour\u201d) is a commercial-stage biotechnology &hellip; Continue reading \"Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-15T20:31:17+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MDc0NiM3NTM4MTEwIzIxNzcxODI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026","datePublished":"2026-04-15T20:31:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/"},"wordCount":293,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MDc0NiM3NTM4MTEwIzIxNzcxODI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/","name":"Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MDc0NiM3NTM4MTEwIzIxNzcxODI=","datePublished":"2026-04-15T20:31:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MDc0NiM3NTM4MTEwIzIxNzcxODI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MDc0NiM3NTM4MTEwIzIxNzcxODI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/951809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=951809"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/951809\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=951809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=951809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=951809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}